 | • レポートコード：B-GIR09D1169 • 出版社/出版日：GlobalInfoResearch / 2019年9月4日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エフィナコナゾールの世界市場について調べ、まとめました。種類別セグメントは、純度≥98％、純度<98％等、用途別セグメントは、爪真菌症、その他等に区分しました。エフィナコナゾールの世界市場概観、メーカー動向、メーカー別エフィナコナゾールシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エフィナコナゾールの市場概観 ・エフィナコナゾールの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エフィナコナゾールの企業別販売動向、市場シェア、市場集中度、競争動向 ・エフィナコナゾールの世界市場規模 ・エフィナコナゾールの北米市場分析（アメリカ、カナダ、メキシコ等） ・エフィナコナゾールのアメリカ市場規模推移 ・エフィナコナゾールのカナダ市場規模推移 ・エフィナコナゾールのメキシコ市場規模推移 ・エフィナコナゾールのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エフィナコナゾールのドイツ市場規模推移 ・エフィナコナゾールのイギリス市場規模推移 ・エフィナコナゾールのロシア市場規模推移 ・エフィナコナゾールのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エフィナコナゾールの日本市場規模推移 ・エフィナコナゾールの中国市場規模推移 ・エフィナコナゾールの韓国市場規模推移 ・エフィナコナゾールのインド市場規模推移 ・エフィナコナゾールの東南アジア市場規模推移 ・エフィナコナゾールの南米市場分析（ブラジル、アルゼンチン等） ・エフィナコナゾールの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エフィナコナゾールの種類別分析/販売量、売上、市場シェア（純度≥98％、純度<98％） ・エフィナコナゾールの用途別分析/市場規模（爪真菌症、その他） ・エフィナコナゾールの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エフィナコナゾールの販売チャネル・代理店・貿易業者・ディーラー分析 |
Efinaconazole is a 14 alpha-demethylase inhibitor indicated in the treatment of fungal infection of the nail, known as onychomycosis.
Scope of the Report:
The worldwide market for Efinaconazole is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Efinaconazole in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
VIRUJ PHARMA
Valeant
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Purity ≥ 98%
Purity ＜ 98%
Market Segment by Applications, can be divided into
Onychomycosis
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Efinaconazole product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Efinaconazole, with price, sales, revenue and global market share of Efinaconazole in 2017 and 2018.
Chapter 3, the Efinaconazole competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Efinaconazole breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Efinaconazole market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Efinaconazole sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Efinaconazole Introduction
1.2 Market Analysis by Type
1.2.1 Purity ≥ 98%
1.2.2 Purity ＜ 98%
1.3 Market Analysis by Applications
1.3.1 Onychomycosis
1.3.2 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 VIRUJ PHARMA
2.1.1 Business Overview
2.1.2 Efinaconazole Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 VIRUJ PHARMA Efinaconazole Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Valeant
2.2.1 Business Overview
2.2.2 Efinaconazole Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Valeant Efinaconazole Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Efinaconazole Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Efinaconazole Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Efinaconazole Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Efinaconazole Manufacturer Market Share in 2018
3.3.2 Top 6 Efinaconazole Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Efinaconazole Market Analysis by Regions
4.1 Global Efinaconazole Sales, Revenue and Market Share by Regions
4.1.1 Global Efinaconazole Sales and Market Share by Regions (2014-2019)
4.1.2 Global Efinaconazole Revenue and Market Share by Regions (2014-2019)
4.2 North America Efinaconazole Sales and Growth Rate (2014-2019)
4.3 Europe Efinaconazole Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Efinaconazole Sales and Growth Rate (2014-2019)
4.5 South America Efinaconazole Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Efinaconazole Sales and Growth Rate (2014-2019)
5 North America Efinaconazole by Country
5.1 North America Efinaconazole Sales, Revenue and Market Share by Country
5.1.1 North America Efinaconazole Sales and Market Share by Country (2014-2019)
5.1.2 North America Efinaconazole Revenue and Market Share by Country (2014-2019)
5.2 United States Efinaconazole Sales and Growth Rate (2014-2019)
5.3 Canada Efinaconazole Sales and Growth Rate (2014-2019)
5.4 Mexico Efinaconazole Sales and Growth Rate (2014-2019)
6 Europe Efinaconazole by Country
6.1 Europe Efinaconazole Sales, Revenue and Market Share by Country
6.1.1 Europe Efinaconazole Sales and Market Share by Country (2014-2019)
6.1.2 Europe Efinaconazole Revenue and Market Share by Country (2014-2019)
6.2 Germany Efinaconazole Sales and Growth Rate (2014-2019)
6.3 UK Efinaconazole Sales and Growth Rate (2014-2019)
6.4 France Efinaconazole Sales and Growth Rate (2014-2019)
6.5 Russia Efinaconazole Sales and Growth Rate (2014-2019)
6.6 Italy Efinaconazole Sales and Growth Rate (2014-2019)
7 Asia-Pacific Efinaconazole by Country
7.1 Asia-Pacific Efinaconazole Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Efinaconazole Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Efinaconazole Revenue and Market Share by Country (2014-2019)
7.2 China Efinaconazole Sales and Growth Rate (2014-2019)
7.3 Japan Efinaconazole Sales and Growth Rate (2014-2019)
7.4 Korea Efinaconazole Sales and Growth Rate (2014-2019)
7.5 India Efinaconazole Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Efinaconazole Sales and Growth Rate (2014-2019)
8 South America Efinaconazole by Country
8.1 South America Efinaconazole Sales, Revenue and Market Share by Country
8.1.1 South America Efinaconazole Sales and Market Share by Country (2014-2019)
8.1.2 South America Efinaconazole Revenue and Market Share by Country (2014-2019)
8.2 Brazil Efinaconazole Sales and Growth Rate (2014-2019)
8.3 Argentina Efinaconazole Sales and Growth Rate (2014-2019)
8.4 Colombia Efinaconazole Sales and Growth Rate (2014-2019)
9 Middle East and Africa Efinaconazole by Countries
9.1 Middle East and Africa Efinaconazole Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Efinaconazole Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Efinaconazole Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Efinaconazole Sales and Growth Rate (2014-2019)
9.3 Turkey Efinaconazole Sales and Growth Rate (2014-2019)
9.4 Egypt Efinaconazole Sales and Growth Rate (2014-2019)
9.5 Nigeria Efinaconazole Sales and Growth Rate (2014-2019)
9.6 South Africa Efinaconazole Sales and Growth Rate (2014-2019)
10 Global Efinaconazole Market Segment by Type
10.1 Global Efinaconazole Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Efinaconazole Sales and Market Share by Type (2014-2019)
10.1.2 Global Efinaconazole Revenue and Market Share by Type (2014-2019)
10.2 Purity ≥ 98% Sales Growth and Price
10.2.1 Global Purity ≥ 98% Sales Growth (2014-2019)
10.2.2 Global Purity ≥ 98% Price (2014-2019)
10.3 Purity ＜ 98% Sales Growth and Price
10.3.1 Global Purity ＜ 98% Sales Growth (2014-2019)
10.3.2 Global Purity ＜ 98% Price (2014-2019)
11 Global Efinaconazole Market Segment by Application
11.1 Global Efinaconazole Sales Market Share by Application (2014-2019)
11.2 Onychomycosis Sales Growth (2014-2019)
11.3 Other Sales Growth (2014-2019)
12 Efinaconazole Market Forecast (2019-2024)
12.1 Global Efinaconazole Sales, Revenue and Growth Rate (2019-2024)
12.2 Efinaconazole Market Forecast by Regions (2019-2024)
12.2.1 North America Efinaconazole Market Forecast (2019-2024)
12.2.2 Europe Efinaconazole Market Forecast (2019-2024)
12.2.3 Asia-Pacific Efinaconazole Market Forecast (2019-2024)
12.2.4 South America Efinaconazole Market Forecast (2019-2024)
12.2.5 Middle East and Africa Efinaconazole Market Forecast (2019-2024)
12.3 Efinaconazole Market Forecast by Type (2019-2024)
12.3.1 Global Efinaconazole Sales Forecast by Type (2019-2024)
12.3.2 Global Efinaconazole Market Share Forecast by Type (2019-2024)
12.4 Efinaconazole Market Forecast by Application (2019-2024)
12.4.1 Global Efinaconazole Sales Forecast by Application (2019-2024)
12.4.2 Global Efinaconazole Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Efinaconazole Picture
Table Product Specifications of Efinaconazole
Figure Global Sales Market Share of Efinaconazole by Types in 2018
Table Efinaconazole Types for Major Manufacturers
Figure Purity ≥ 98% Picture
Figure Purity ＜ 98% Picture
Figure Efinaconazole Sales Market Share by Applications in 2018
Figure Onychomycosis Picture
Figure Other Picture
Figure United States Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure France Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure UK Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure China Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure India Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Efinaconazole Revenue (Value) and Growth Rate (2014-2024)
Table VIRUJ PHARMA Basic Information, Manufacturing Base and Competitors
Table VIRUJ PHARMA Efinaconazole Type and Applications
Table VIRUJ PHARMA Efinaconazole Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Valeant Basic Information, Manufacturing Base and Competitors
Table Valeant Efinaconazole Type and Applications
Table Valeant Efinaconazole Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Efinaconazole Sales by Manufacturer (2017-2018)
Figure Global Efinaconazole Sales Market Share by Manufacturer in 2017
Figure Global Efinaconazole Sales Market Share by Manufacturer in 2018
Table Global Efinaconazole Revenue by Manufacturer (2017-2018)
Figure Global Efinaconazole Revenue Market Share by Manufacturer in 2017
Figure Global Efinaconazole Revenue Market Share by Manufacturer in 2018
Figure Top 3 Efinaconazole Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Efinaconazole Manufacturer (Revenue) Market Share in 2018
Figure Global Efinaconazole Sales and Growth Rate (2014-2019)
Figure Global Efinaconazole Revenue and Growth Rate (2014-2019)
Table Global Efinaconazole Sales by Regions (2014-2019)
Table Global Efinaconazole Sales Market Share by Regions (2014-2019)
Table Global Efinaconazole Revenue by Regions (2014-2019)
Figure Global Efinaconazole Revenue Market Share by Regions in 2014
Figure Global Efinaconazole Revenue Market Share by Regions in 2018
Figure North America Efinaconazole Sales and Growth Rate (2014-2019)
Figure Europe Efinaconazole Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Efinaconazole Sales and Growth Rate (2014-2019)
Figure South America Efinaconazole Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Efinaconazole Sales and Growth Rate (2014-2019)
Figure North America Efinaconazole Revenue and Growth Rate (2014-2019)
Table North America Efinaconazole Sales by Countries (2014-2019)
Table North America Efinaconazole Sales Market Share by Countries (2014-2019)
Figure North America Efinaconazole Sales Market Share by Countries in 2014
Figure North America Efinaconazole Sales Market Share by Countries in 2018
Table North America Efinaconazole Revenue by Countries (2014-2019)
Table North America Efinaconazole Revenue Market Share by Countries (2014-2019)
Figure North America Efinaconazole Revenue Market Share by Countries in 2014
Figure North America Efinaconazole Revenue Market Share by Countries in 2018
Figure United States Efinaconazole Sales and Growth Rate (2014-2019)
Figure Canada Efinaconazole Sales and Growth Rate (2014-2019)
Figure Mexico Efinaconazole Sales and Growth Rate (2014-2019)
Figure Europe Efinaconazole Revenue and Growth Rate (2014-2019)
Table Europe Efinaconazole Sales by Countries (2014-2019)
Table Europe Efinaconazole Sales Market Share by Countries (2014-2019)
Table Europe Efinaconazole Revenue by Countries (2014-2019)
Figure Europe Efinaconazole Revenue Market Share by Countries in 2017
Figure Europe Efinaconazole Revenue Market Share by Countries in 2018
Figure Germany Efinaconazole Sales and Growth Rate (2014-2019)
Figure UK Efinaconazole Sales and Growth Rate (2014-2019)
Figure France Efinaconazole Sales and Growth Rate (2014-2019)
Figure Russia Efinaconazole Sales and Growth Rate (2014-2019)
Figure Italy Efinaconazole Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Efinaconazole Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Efinaconazole Sales by Countries (2014-2019)
Table Asia-Pacific Efinaconazole Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Efinaconazole Sales Market Share by Countries 2018
Table Asia-Pacific Efinaconazole Revenue by Countries (2014-2019)
Figure Asia-Pacific Efinaconazole Revenue Market Share by Countries 2018
Figure China Efinaconazole Sales and Growth Rate (2014-2019)
Figure Japan Efinaconazole Sales and Growth Rate (2014-2019)
Figure Korea Efinaconazole Sales and Growth Rate (2014-2019)
Figure India Efinaconazole Sales and Growth Rate (2014-2019)
Figure Southeast Asia Efinaconazole Sales and Growth Rate (2014-2019)
Figure South America Efinaconazole Revenue and Growth Rate (2014-2019)
Table South America Efinaconazole Sales by Countries (2014-2019)
Table South America Efinaconazole Sales Market Share by Countries (2014-2019)
Figure South America Efinaconazole Sales Market Share by Countries in 2018
Table South America Efinaconazole Revenue by Countries (2014-2019)
Table South America Efinaconazole Revenue Market Share by Countries (2014-2019)
Figure South America Efinaconazole Revenue Market Share by Countries in 2018
Figure Brazil Efinaconazole Sales and Growth Rate (2014-2019)
Figure Argentina Efinaconazole Sales and Growth Rate (2014-2019)
Figure Colombia Efinaconazole Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Efinaconazole Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Efinaconazole Sales by Countries (2014-2019)
Table Middle East and Africa Efinaconazole Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Efinaconazole Sales Market Share by Countries in 2018
Table Middle East and Africa Efinaconazole Revenue by Countries (2014-2019)
Table Middle East and Africa Efinaconazole Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Efinaconazole Revenue Market Share by Countries in 2014
Figure Middle East and Africa Efinaconazole Revenue Market Share by Countries in 2018
Figure Saudi Arabia Efinaconazole Sales and Growth Rate (2014-2019)
Figure UAE Efinaconazole Sales and Growth Rate (2014-2019)
Figure Egypt Efinaconazole Sales and Growth Rate (2014-2019)
Figure Nigeria Efinaconazole Sales and Growth Rate (2014-2019)
Figure South Africa Efinaconazole Sales and Growth Rate (2014-2019)
Table Global Efinaconazole Sales by Type (2014-2019)
Table Global Efinaconazole Sales Share by Type (2014-2019)
Table Global Efinaconazole Revenue by Type (2014-2019)
Table Global Efinaconazole Revenue Share by Type (2014-2019)
Figure Global Purity ≥ 98% Sales Growth (2014-2019)
Figure Global Purity ≥ 98% Price (2014-2019)
Figure Global Purity ＜ 98% Sales Growth (2014-2019)
Figure Global Purity ＜ 98% Price (2014-2019)
Table Global Efinaconazole Sales by Application (2014-2019)
Table Global Efinaconazole Sales Share by Application (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Efinaconazole Sales, Revenue and Growth Rate (2019-2024)
Table Global Efinaconazole Sales Forecast by Regions (2019-2024)
Table Global Efinaconazole Market Share Forecast by Regions (2019-2024)
Figure North America Sales Efinaconazole Market Forecast (2019-2024)
Figure Europe Sales Efinaconazole Market Forecast (2019-2024)
Figure Asia-Pacific Sales Efinaconazole Market Forecast (2019-2024)
Figure South America Sales Efinaconazole Market Forecast (2019-2024)
Figure Middle East and Africa Sales Efinaconazole Market Forecast (2019-2024)
Table Global Efinaconazole Sales Forecast by Type (2019-2024)
Table Global Efinaconazole Market Share Forecast by Type (2019-2024)
Table Global Efinaconazole Sales Forecast by Application (2019-2024)
Table Global Efinaconazole Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の高純度テルル化スズ市場予測（～2024年） Scope of the Report: The worldwide market for High Purity Tin Telluride is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the High Purity T…- 世界のタバボロール市場予測（～2024年） It is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Scope of the Report: The worldwide market for Tavaborole is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US…
- 世界の高純度ネオペンチルグリコール市場予測（～2024年） Neopentyl glycol (NPG, IUPAC name 2,2-dimethyl-1,3-propanediol) is an important industrial intermediate used in the synthesis of polyesters, especially resins for airplane or boat manufacturing. Scope of the Report: The worldwide market for High Purity Neopentyl Glycol is expected to grow at a CAGR …
- 世界の高純度リン化亜鉛市場予測（～2024年） Scope of the Report: The worldwide market for High Purity Zinc Phosphide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the High Purity …
- 世界の高純度テルル化亜鉛市場予測（～2024年） Scope of the Report: The worldwide market for High Purity Zinc Telluride is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the High Purity …